结论：调整辅料后处方经放大生产验证，具有生产可操作性。
Conclusion:The adjusted prescription can be well put into practice.
结果：以此工艺条件，进行中试生产，所得芍芍苷占处方生药量的比为0.208%。
As optimum technology condition. Results: Under the technology condition, the middle trial was conducted.
结果：以此工艺条件，进行中试生产，所得芍芍苷占处方生药量的比为0.208%。
As optimum technology condition. Results: Under the technology condition, the middle trial was conducted.
应用推荐